Using the CRISPR/Cas9 system, each tumor cell receives a singular genetic knockdown (Manguso et al, 2017). A knockdown is the disruption of the nucleotide sequence of a gene is disrupted, creating a non or dysfunctional form of the protein.
Using the CRISPR/Cas9 system, each tumor cell receives a singular genetic knockdown (Manguso et al, 2017). A knockdown is the disruption of the nucleotide sequence of a gene is disrupted, creating a non or dysfunctional form of the protein.